Sandbox Reserved 1502

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (19:28, 11 January 2019) (edit) (undo)
 
(69 intermediate revisions not shown.)
Line 1: Line 1:
-
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
+
<scene name='80/802676/Site_of_interaction/1'>Text To Be Displayed</scene>{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
=='''3lpt - HIV integrase'''==
=='''3lpt - HIV integrase'''==
 +
<StructureSection load='3lpt' size='340' side='right' caption='[[3lpt]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
<StructureSection load='3lpt' size='340' side='right' caption='[[3lpt]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
-
3lt is an integrase of the HIV, the Human Immunodeficiency Virus. An integrase is an enzyme produced by a retrovirus to integrate its genetic material into the DNA of the infected cell.
+
The 3lpt is an integrase of the HIV, the Human Immunodeficiency Virus. An integrase is an enzyme produced by a retrovirus to integrate its genetic material into the DNA of the infected cell. It is one of three enzymes of HIV, the others being the Reverse Transcriptase and the Protease.
 +
 
 +
== Structural highlights ==
 +
 
 +
 
 +
<scene name='80/802676/Hiv_integrase_3lpt/8'>HIV Integrase 3D structure</scene>
 +
 
 +
<table><tr><td colspan='2'>
 +
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=723:(6-CHLORO-2-OXO-4-PHENYL-1,2-DIHYDROQUINOLIN-3-YL)ACETIC+ACID'>723</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=P03:2-[3-[3-(2-HYDROXYETHOXY)PROPOXY]PROPOXY]ETHANOL'>P03</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
 +
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>
 +
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1hyv|1hyv]], [[3lpu|3lpu]]</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3lpt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3lpt OCA], [http://pdbe.org/3lpt PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3lpt RCSB], [http://www.ebi.ac.uk/pdbsum/3lpt PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3lpt ProSAT]</span></td></tr>
 +
</table>
 +
 
 +
 
 +
== Function ==
 +
 
 +
An integrase is an enzyme required for the integration of viral DNA into the host genome. The process of integration can be divided into two sequential reactions. In the first one, named 3'-processing, the enzyme removes di- or trinucleotides from viral DNA ends to expose 3′-hydroxyls attached to CA dinucleotides. The second step is the insertion of the processed 3′-viral DNA ends into the host chromosomal DNA by a trans-esterification reaction. This is called the strand transfer.
 +
The HIV integrase is the enzyme responsible for the integration of the HIV's viral DNA into the host cell.
 +
 
 +
 
 +
== Structure ==
 +
 
 +
HIV-1 integrase is composed of three domains: the N-terminal (residues 1-49), the core domain (residues 50-212) and the C-terminal domain (residues 213-288).[http://www.jbc.org/content/276/26/23213/F2.expansion.html]
 +
 
 +
 
 +
'''The three domain of the HIV integrase:'''
 +
 
 +
[[Image:Domain_HIV_Integrase.jpg]] [http://www.jbc.org/content/276/26/23213.full]
 +
 
 +
'''HIV Integrase sequence:'''
 +
 
 +
[[Image:HIV integrase sequenc.jpg]][https://www.uniprot.org/uniprot/Q76353#sequences]
 +
Length:288, Mass (Da):32,199
 +
 
 +
'''Sequence chain view of the HIV Integrase:'''
 +
 
 +
[[Image:HIV Integrase sequence.jpg]] [http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3lpt]
 +
 
 +
====Structure and role of the core domain====
 +
 
 +
The catalytic core domain contains three acidic residues, the D,D-35-E motif, comprising residues Asp64, Asp116, and Glu152. By analogy with models of catalysis by DNA polymerases, it has been proposed that coordination of divalent metal ion to these residues plays a key role in catalysis. The catalytic residues Asp64, Asp116, and Glu152 of HIV integrase are in close proximity, coordinate divalent metal ion, and define the active site. The residues comprising the active site region exhibit considerable flexibility. That suggests that binding of DNA substrate is required to impose the precise configuration of residues that are required for catalysis.
 +
 
 +
[[Image:Core enzyme.jpg]] [http://www.jbc.org/content/276/26/23213.full]
 +
 
 +
<scene name='80/802676/Core_enzyme/2'>Here is the 3D structure of the core domain</scene>
 +
 
 +
 
 +
====Structure and role of the N ter domain====
 +
 
 +
The N-terminal domain of HIV-1 integrase contains a conserved pair of His and Cys residues, a motif similar to the zinc-coordinating residues of zinc fingers. This domain binds zinc but its structure is totally different from that of zinc fingers. It consists of a bundle of three α-helices. This domain is necessary for the oligomerization of the integrase.
 +
 
 +
[[Image:Nter-domain.jpg]] [http://www.jbc.org/content/276/26/23213.full]
 +
 
 +
<scene name='80/802676/N-ter_domain/2'>Here is the 3D structure of the N-ter domain of the HIV integrase</scene>
 +
<table><tr><td colspan='2'></td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
 +
</table>
 +
 
 +
====Structure and role of the C ter domain====
 +
 
 +
Here is the structure of the C-ter domain :
-
== '''Function''' ==
+
[[Image:C-ter domain.jpg]] [http://www.jbc.org/content/276/26/23213.full]
 +
The C-terminal domain interacts in a non-specific way with DNA and would, therefore, play a stabilizing role of integrase-ADN interactions.
-
== '''Structure''' ==
 
 +
== Interaction between the HIV integrase and LEDGF/p75 ==
 +
LEDGF/p75, or Lens epithelium-derived growth factor, is a cellular cofactor of HIV integrase. It promotes the viral integration of the retrovirus by tethering the preintegration complex to the chromatin. Research on the LEDGF/p75-integrase interaction [https://www.nature.com/articles/nchembio.370] shows that it can be inhibited by using a molecule which will take the place of LEDGF/p75 on its binding site. Thus, the viral DNA will not be inserted into the genome of the host cell and the replication of HIV won't be possible.
-
<scene name='80/802676/Hiv_integrase_3lpt/8'>HIV Integrase 3lpt</scene>
+
====Use of antiviral to inhibit the LEDGF/p75-integrase interaction ====
-
== '''HIV''' ==
+
An antiviral refers to a molecule disrupting the replication cycle of one or more viruses, thus allowing to slow down but rarely to stop a viral infection. Antiviral targeting specific regions of the integrase are used to prevent the replication of HIV. For example, the 2-(quinolin-3-yl)acetic acid interacts with <scene name='80/802676/Site_of_interaction/7'>the binding site of the LEDGF/p75 cofactor</scene>. More precisely, it binds to the residues E170, H171, and T174. This site is situated in the core domain of the enzyme. Once it is fixed into the core domain, the LEDGF/p75 will not be able to join and viral integration of the retrovirus will not be possible anymore.
 +
The whole complex between the integrase and the cofactor is displayed on the Proteopedia page [[2b4j]].
-
HIV is a virus spread through certain body fluids that attacks the body’s immune system, specifically the CD4 cells, often called T cells. Over time, HIV can destroy so many of these cells that the body can’t fight off infections and disease. These special cells help the immune system fight off infections. Untreated, HIV reduces the number of CD4 cells (T cells) in the body. This damage to the immune system makes it harder and harder for the body to fight off infections and some other diseases. Opportunistic infections or cancers take advantage of a very weak immune system and signal that the person has AIDS. Learn more about the stages of HIV and how to know whether you’re infected.
 
-
HIV stands for human immunodeficiency virus. It is the virus that can lead to acquired immunodeficiency syndrome, or AIDS, if not treated. Unlike some other viruses, the human body can’t get rid of HIV completely, even with treatment. So once you get HIV, you have it for life.
+
== HIV ==
-
HIV attacks the body’s immune system, specifically the CD4 cells (T cells), which help the immune system fight off infections. Untreated, HIV reduces the number of CD4 cells (T cells) in the body, making the person more likely to get other infections or infection-related cancers. Over time, HIV can destroy so many of these cells that the body can’t fight off infections and disease. These opportunistic infections or cancers take advantage of a very weak immune system and signal that the person has AIDS, the last stage of HIV infection.
+
HIV stands for human immunodeficiency virus. It is a retrovirus virus that damages the cells in the immune system and weakens the ability to fight everyday infections and disease. Copied into DNA, HIV is inserted into the genome of the infected cell thanks to integrases. To replicate and diffuse himself it attacks the body’s immune system, specifically the CD4 cells (T cells), which help fight off infections. As soon as HIV enters an individual, it accumulates in the cells and forms reservoirs of latent viruses in a few days or even hours. These reservoirs persist for life.
-
No effective cure currently exists, but with proper medical care, HIV can be controlled. The medicine used to treat HIV is called antiretroviral therapy or ART. If taken the right way, every day, this medicine can dramatically prolong the lives of many people infected with HIV, keep them healthy, and greatly lower their chance of infecting others. Before the introduction of ART in the mid-1990s, people with HIV could progress to AIDS in just a few years. Today, someone diagnosed with HIV and treated before the disease is far advanced can live nearly as long as someone who does not have HIV.[https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids]
+
No cure currently exists, but HIV can be controlled by using antiretroviral therapy or ART. It is a combination of antiretroviral drugs to maximally suppress the HIV virus and stop the progression of HIV disease. In the mid-1990s, before the introduction of ART, people with HIV could progress to AIDS in just a few years. Today, someone diagnosed with HIV and treated before the disease is far advanced can live nearly as long as someone who does not have HIV.[https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids]
-
=='''Disease : AIDS'''===
+
== AIDS ==
-
AIDS is the most severe phase of HIV infection. People with AIDS have such badly damaged immune systems that they get an increasing number of severe illnesses, called opportunistic infections.
+
AIDS is the ultimate stage of infection with the human immunodeficiency virus. The word AIDS stands for Acquired Immunodeficiency Syndrome. People with AIDS get an increasing number of severe illnesses, called opportunistic infections, because of there damaged immune system. Are considered to have progressed to AIDS individual whose number of CD4 cells is lower than 200 cells per cubic millimeter of blood (200 cells/mm3). CD4 counts are between 500 and 1,600 cells/mm3 for someone with a healthy immune system. Developing one or more opportunistic illnesses, regardless of the CD4 count is also an indicator showing the progression to AIDS.[https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids]
-
This is the stage of HIV infection that occurs when your immune system is badly damaged and you become vulnerable to opportunistic infections. When the number of your CD4 cells falls below 200 cells per cubic millimeter of blood (200 cells/mm3), you are considered to have progressed to AIDS. (In someone with a healthy immune system, CD4 counts are between 500 and 1,600 cells/mm3.) You are also considered to have progressed to AIDS if you develop one or more opportunistic illnesses, regardless of your CD4 count.
 
-
Without treatment, people who progress to AIDS typically survive about 3 years. Once you have a dangerous opportunistic illness, life-expectancy without treatment falls to about 1 year. ART can be helpful for people who have AIDS when diagnosed and can be lifesaving. Treatment is likely to benefit people with HIV no matter when it is started, but people who start ART soon after they get HIV experience more benefits from treatment than do people who start treatment after they have developed AIDS.
 
-
People living with HIV may progress through these stages at different rates, depending on a variety of factors, including their genetic makeup, how healthy they were before they were infected, how much virus they were exposed to and its genetic characteristics, how soon after infection they are diagnosed and linked to care and treatment, whether they see their healthcare provider regularly and take their HIV medications as directed, and different health-related choices they make, such as decisions to eat a healthful diet, exercise, and not smoke.[https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids]
+
==See also==
 +
http://proteopedia.org/wiki/index.php/2b4j :integrase ligated with the cofactor LEDGF/p75
-
</StructureSection>
 
== References ==
== References ==
 +
https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/what-are-hiv-and-aids
 +
https://www-nature-com.scd-rproxy.u-strasbg.fr/articles/nchembio.370
 +
https://www.uniprot.org/uniprot/Q76353#sequences
 +
http://pfam.xfam.org/family/rve
 +
http://pfam.xfam.org/protein/Q76353_9HIV1
 +
https://www.rcsb.org/3d-view/3LPT/1
 +
https://en.wikipedia.org/wiki/Diethylene_glycol
 +
https://microbewiki.kenyon.edu/index.php/HIV-1_Pre-Integration_Complex
 +
https://www.uniprot.org/uniprot/Q76353
 +
https://www.rcsb.org/structure/3lpt
 +
http://proteopedia.org/wiki/index.php/Retroviral_Integrase
 +
http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3lpt
<references/>
<references/>

Current revision

This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

3lpt - HIV integrase

3lpt, resolution 2.00Å

Drag the structure with the mouse to rotate
Personal tools